(2025) Tofacitinib for Refractory Thyroid Eye Disease. Jama Ophthalmology. pp. 1073-1075. ISSN 2168-6165
Full text not available from this repository.
Official URL: http://apps.webofknowledge.com/InboundService.do?F...
Abstract
This case report describes management of refractory thyroid eye disease in 2 patients using the Janus kinase 1/3 inhibitor tofacitinib.
| Item Type: | Article |
|---|---|
| Keywords: | Ophthalmology |
| Page Range: | pp. 1073-1075 |
| Journal or Publication Title: | Jama Ophthalmology |
| Journal Index: | ISI |
| Volume: | 143 |
| Number: | 12 |
| Identification Number: | https://doi.org/10.1001/jamaophthalmol.2025.3974 |
| ISSN: | 2168-6165 |
| Depositing User: | خانم ناهید ضیائی |
| URI: | http://eprints.mui.ac.ir/id/eprint/33444 |
Actions (login required)
 |
View Item |